ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1662638
This article is part of the Research TopicThe Insights of Multi-Omics into the Microenvironment After Tumor Metastasis: A Paradigm Shift in Molecular Targeting Modeling and Immunotherapy for Advanced Cancer PatientsView all 13 articles
Diagnostic Value of Thyroid-Related Serological Indicators and Pan-Immune Inflammation Value for Differentiated Thyroid Carcinoma
Provisionally accepted- 1Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 3Tarim University, Aral, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Over the past decade, the remarkable rise in differentiated thyroid carcinoma (DTC) incidence, combined with the limitations of conventional diagnostic approaches, have prompted this study to explore the diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value (PIV) for DTC, based on advancements in molecular biology and immunology.: Based on postoperative pathological diagnosis, the present retrospective research comprised 112 individuals afflicted with DTC (observation group) and 93 individuals having benign thyroid tumors (control group) from January 2023 to January 2025. Differences in clinical data between the two groups were analyzed via univariate statistical methods. Logistic regression analyses identified influencing factors, while diagnostic value of thyroid-related serological indicators and PIV levels were evaluated through receiver operating characteristic analysis.Results: Intergroup differences regarding the levels of thyroxine (T4), free thyroxine (FT4), thyroid-stimulating hormone (TSH), thyroglobulin (Tg), lymphocyte count, monocyte count, and PIV were found to be significant (p<0.05). Additionally, negative correlation of lymphocyte count with DTC was noted by univariate binary logistic regression (odds ratio [OR] = 0.243, 95% confidence interval [CI]: 0.143-0.411]). TSH (OR=2.458, 95% CI: 1.690-3.575), FT4 (OR=1.383, 95% CI:1.205-1.588), Tg (OR=1.008, 95% CI: 1.001-1.015), and PIV (OR=1.003, 95% CI: 1.000-1.005) were identified as independent influencing factors for DTC, and the area under the curve for their combination was 0.860 (95% CI: 0.809-0.912, sensitivity: 86.2%, specificity: 77.2%).This retrospective study suggested that TSH, FT4, Tg, and PIV were positively correlated with DTC, and their combination yielded the best diagnostic performance. It highlighted the potential utility of PIV as a novel immune-inflammatory biomarker and provided support for the development of DTC diagnosis.
Keywords: immune-inflammatory biomarkers, pan-immune inflammation value, diagnostic value, thyroid-related serological indicators, Differentiated thyroid carcinoma
Received: 09 Jul 2025; Accepted: 04 Aug 2025.
Copyright: © 2025 Wen, Yi, Shi, Wan, wang, Li and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Tian Li, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Huixia Liu, Tarim University, Aral, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.